Strategic transaction consulting
The purchase and sale of companies has become more and more a suitable instrument in the implementation of the respective corporate strategy, also in the healthcare sector, in recent years. For companies, the questions of niche strategies or broad offer approach arise. In addition, transactions in the hospital sector are not infrequently the subject of criticism. This makes it all the more important to have a coherent transaction strategy in place.
Oberender’s M&A team has been involved in a large number of such transactions in recent years and has managed the entire process from decision-making and project management to closing and subsequent post-merger integration for a large number of German and international clients. In doing so, we have been active on both the buyer and seller side.
Our consulting services include the preparation of social plans, personnel transfers and releases, short-term takeover of personnel management as well as support in reorganization and restructuring measures.
We always keep an eye on implementation options – that’s what Oberender stands for: no fantasies, but realistic recommendations, which we help you implement if you wish.
Business plan, company valuation and purchase price derivation.
The profitability of a transaction always depends on the purchase price to be paid for the company to be acquired in comparison to the added value for the buyer resulting from the transaction. So the focus is on the question: what is the earnings value of the company against the background of a business plan to be developed and implemented? And what purchase price can I accept against the background of a risk to be calculated?
Oberender’s M&A team examines questions regarding the current value of the company as well as synergies, additional revenue and cost potentials in order to increase the future value. Methodically, multiples are used for company valuation and purchase price determination as well as the “classic” valuation methods (DCF method, capitalized earnings value, net asset value). The final assessment of a company’s value as well as the review, plausibility check or elaboration of an underlying business plan incorporate the vast experience of our M&A managers, which we were able to gather in consulting in responsible M&A positions for other consultancies and hospital operators
Commercial Due Dilligence
Commercial due diligence is often referred to as the supreme discipline in the M&A process. It provides the essential information on the market environment in which a company operates, how it can meet the challenges of the market and how these conditions affect the business plan, in particular the revenue side.
One of our core competencies in transaction processes is therefore the analysis of the market and competitive environment, including a classification of the company in the regulatory environment and the potential there. On the basis of a well-founded analysis of key figures, we sharpen our clients’ view of the future and thus help them to better and more accurately assess the desired value of a transaction. This significantly increases the likelihood of a successful transaction.
Commercial due diligence comprises five building blocks and is rounded off with a potential business plan validation:
- Business model
- Market analysis
- Competitive analysis
- Regulations
- Upsides & Downsides
Start-up investor consulting
For almost 10 years now, our employees have been maintaining contact with founders in the healthcare sector. We are continuously expanding our network. Healthcare start-ups are playing an increasingly important role in the market, because it is often only through them that a necessary innovation push is created. The employees of Oberender AG know both sides: the traditional healthcare system with its complex regulations and the young companies that dare to think outside the box.
We know the above-average risk of investing in start-ups and, through our close cooperation with founders, we are aware of the special characteristics of these companies. We are able to reduce this investment risk for investors through our specialist expertise in the healthcare sector and our large databases. We always align our activities very flexibly to the size of the start-up and the investment.
Post-merger integration
Notwithstanding the growing number of corporate mergers and acquisitions in healthcare, too little attention is often paid to the integration of merging companies. Lack of accuracy in data analysis and too rough conceptualizations lay the foundation for this. Lack of consistency and professionalism in project management exacerbate the problem. Thus, the post-merger phase remains the riskiest phase of the transaction process.
Oberender supports the integration phase, for example, by setting up and supporting a project management office, managing the PMI project portfolio and designing and managing individual integration projects. Within the framework of interim management, we also provide management personnel for this task if required.
After investments in healthcare start-ups, the teams of Oberender AG also provide support in the context of stabilizing the business, market access and growth course, certainly also in the medium term, for example in the realization of a buy-and-build strategy.